Victory Capital Management Inc. bought a new position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 16,655 shares of the industrial products company's stock, valued at approximately $584,000. Victory Capital Management Inc. owned about 0.07% of Proto Labs at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sterling Capital Management LLC lifted its holdings in shares of Proto Labs by 764.1% during the fourth quarter. Sterling Capital Management LLC now owns 795 shares of the industrial products company's stock worth $31,000 after purchasing an additional 703 shares during the period. GAMMA Investing LLC increased its holdings in Proto Labs by 249.4% in the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 661 shares during the period. Quarry LP raised its position in Proto Labs by 175.7% during the 4th quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock worth $62,000 after purchasing an additional 1,010 shares during the last quarter. CWM LLC raised its position in Proto Labs by 50.4% during the 1st quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock worth $64,000 after purchasing an additional 617 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in Proto Labs during the 4th quarter worth about $192,000. 84.54% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have recently weighed in on PRLB. Wall Street Zen raised Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Craig Hallum upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 target price on the stock in a report on Friday. Finally, Cantor Fitzgerald raised their price target on shares of Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a report on Friday.
Read Our Latest Analysis on Proto Labs
Proto Labs Trading Up 0.3%
Shares of Proto Labs stock opened at $43.27 on Friday. The business has a 50-day moving average price of $39.29 and a two-hundred day moving average price of $38.59. Proto Labs, Inc. has a 1-year low of $25.75 and a 1-year high of $46.73. The company has a market cap of $1.03 billion, a P/E ratio of 72.12 and a beta of 1.33.
Proto Labs (NYSE:PRLB - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.33 by $0.08. The business had revenue of $135.06 million during the quarter, compared to analysts' expectations of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%. The firm's revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.38 earnings per share. Equities research analysts forecast that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.
Proto Labs Company Profile
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.